5.48  0.07 (1.29%)		11-03 13:20
Open: 5.36 High: 5.64 Volume: 956,727		Pre. Close: 5.41 Low: 5.2508 Market Cap: 649(M)

Short term
Mid term
Targets	6-month :	10576.3	1-year :	17111.2
Resists	First :	9055.02	Second :	14650
Pivot price	4.72
Supports	First :	3.47	Second :	2.88
MAs	MA(5) :	5.21	MA(20) :	0
	MA(100) :	0	MA(250) :	0
MACD	MACD :	0	Signal :	0
%K %D	K(14,3) :	96.5	D(3) :	0
RSI	RSI(14): 0
52-week	High :	5.52	Low :	3.47

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
[ POM ] has closed below upper band by 4.8%. Bollinger Bands are 0% narrower than normal.

If tomorrow:	Open lower	Open higher
High:	5.53 - 5.56	5.56 - 5.58
Low:	5.15 - 5.18	5.18 - 5.2
Close:	5.36 - 5.41	5.41 - 5.45

Pomdoctor Limited, through its subsidiaries, offers an online B2C portal to sell pharmaceutical products. The company develops an online medical services platform for chronic diseases in China. The company focuses on chronic disease management and pharmaceutical services and offers platform for medical services, which connects patients to doctors and pharmaceutical products. The company's business primarily consists of internet hospital and pharmaceutical supply chain, connecting users, pharmacies, suppliers, medical professionals, and other healthcare participants. The company was founded in 2010 and is headquartered in Guangzhou, China.

Fri, 17 Oct 2025
Citi Appointed as Depositary Bank for POMDOCTOR LIMITED’s ADR Program - Bluefield Daily Telegraph

Fri, 17 Oct 2025
Citi Appointed as Depositary Bank for POMDOCTOR LIMITED’s ADR Program - Business Wire

Fri, 10 Oct 2025
PomDoctor completes U.S. listing ahead of looming Nasdaq crackdown - thebambooworks.com

Fri, 10 Oct 2025
Pomdoctor closes $20M IPO to grow mobile health platform in China - BioWorld MedTech

Fri, 10 Oct 2025
Should You Buy POM Stock After the PomDoctor IPO? - Barchart.com

Fri, 10 Oct 2025
POMDOCTOR LIMITED Announces Full Exercise and Closing of Underwriter's Over-Allotment Option - Yahoo Finance

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Underperform
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Underperform
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Underperform
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Underperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Underperform
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Underperform

Exchange: NASDAQ
Sector: Healthcare
Industry: Medical - Pharmaceuticals
Shares Out	106 (M)
Shares Float	2 (M)
Held by Insiders	0 (%)
Held by Institutions	0 (%)
Shares Short	120 (K)
Shares Short P.Month	0 (K)

EPS	-0.04
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	-59.78
Profit Margin	-41.9 %
Operating Margin	-7.7 %
Return on Assets (ttm)	-26.2 %
Return on Equity (ttm)	0 %
Qtrly Rev. Growth	8.6 %
Gross Profit (p.s.)	0.44
Sales Per Share	3.22
EBITDA (p.s.)	-0.23
Qtrly Earnings Growth	0 %
Operating Cash Flow	-16 (M)
Levered Free Cash Flow	-10 (M)

PE Ratio	-136.75
PEG Ratio	0
Price to Book value	-0.1
Price to Sales	1.69
Price to Cash Flow	-36.02

Dividend	0
Forward Dividend	0
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.